Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 11INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 4Other 2

Conditions

Mucositis 27Opioid-Induced Constipation 20Constipation 18Head and Neck Neoplasms 14Stomatitis 13Pain 12Neoplasms 7Obesity 6Intestinal Diseases 5Bronchiolitis Obliterans Syndrome 5Oral Ulcer 3Lymphoma, Follicular 3Hematologic Neoplasms 3Chemotherapy-induced Peripheral Neuropathy 3Breast Neoplasms 3Xerostomia 2Venous Thromboembolism 2Tumor Lysis Syndrome 2Thrombocytopenia 2Teratogenesis 2Sexual Dysfunctions, Psychological 2Sexual Dysfunction, Physiological 2Renal Insufficiency 2Prostatic Neoplasms 2Peripheral Nervous System Diseases 2Overweight 2Obesity, Morbid 2Neutropenia 2Myocardial Infarction 2Myelodysplastic Syndromes 2

Interventions

Radiotherapy 2Fibroblast Growth Factor 7 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Xerostomia × Other × Clear all
NCT02990468 2023-03-15

BMX-HN

BioMimetix JV, LLC

Phase 1/2 Completed
29 enrolled 14 charts
Head & NeckOther

Head and Neck Neoplasms, Xerostomia, Mucositis

NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Swedish Orphan Biovitrum

Phase 3 Completed
188 enrolled 19 charts
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡